Log in to save to my catalogue

Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fat...

Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_2337_db06_0062

Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects

About this item

Full title

Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects

Publisher

Alexandria, VA: American Diabetes Association

Journal title

Diabetes (New York, N.Y.), 2006-08, Vol.55 (8), p.2277-2285

Language

English

Formats

Publication information

Publisher

Alexandria, VA: American Diabetes Association

More information

Scope and Contents

Contents

Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and
Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects
Gautam K. Bandyopadhyay ,
Joseph G. Yu ,
Jachelle Ofrecio and
Jerrold M. Olefsky
From the Department of Medicine, Division of Endocrinol...

Alternative Titles

Full title

Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_2337_db06_0062

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_2337_db06_0062

Other Identifiers

ISSN

0012-1797

E-ISSN

1939-327X

DOI

10.2337/db06-0062

How to access this item